Plus Therapeutics Prices Upsized $15 Million Public Offering

MT Newswires Live01-15

Plus Therapeutics (PSTV) said Wednesday it priced an upsized underwritten public offering of about 39.5 million units at $0.38 each, expected to raise approximately $15 million in gross proceeds.

Each unit comprised one share of common stock and one warrant, according to a statement.

Underwriters have been granted a 30-day option to buy up to an additional 5.9 million shares and/or shares underlying the warrants to cover potential over-allotments, the company said.

Net proceeds will be used for working capital and general corporate purposes, it added.

The offering is expected to close on Thursday.

Shares of the company were down more than 41% in recent trading.

Price: 0.28, Change: -0.19, Percent Change: -41.44

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603641984?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-15 03:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603641984","market":"fut","top_or_hot":-1,"title":"Plus Therapeutics Prices Upsized $15 Million Public Offering","media":"MT Newswires Live","content":"<html><body><p> Plus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (PSTV) said Wednesday it priced an upsized underwritten public offering of about 39.5 million units at $0.38 each, expected to raise approximately $15 million in gross proceeds.</p><p>Each unit comprised one share of common stock and one warrant, according to a statement.</p><p>Underwriters have been granted a 30-day option to buy up to an additional 5.9 million shares and/or shares underlying the warrants to cover potential over-allotments, the company said.</p><p>Net proceeds will be used for working capital and general corporate purposes, it added.</p><p>The offering is expected to close on Thursday.</p><p>Shares of the company were down more than 41% in recent trading.</p><p>Price: 0.28, Change: -0.19, Percent Change: -41.44</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Plus Therapeutics Prices Upsized $15 Million Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPlus Therapeutics Prices Upsized $15 Million Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-15 03:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Plus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (PSTV) said Wednesday it priced an upsized underwritten public offering of about 39.5 million units at $0.38 each, expected to raise approximately $15 million in gross proceeds.</p><p>Each unit comprised one share of common stock and one warrant, according to a statement.</p><p>Underwriters have been granted a 30-day option to buy up to an additional 5.9 million shares and/or shares underlying the warrants to cover potential over-allotments, the company said.</p><p>Net proceeds will be used for working capital and general corporate purposes, it added.</p><p>The offering is expected to close on Thursday.</p><p>Shares of the company were down more than 41% in recent trading.</p><p>Price: 0.28, Change: -0.19, Percent Change: -41.44</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2603641984","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603641984","pubTimestamp":1768420176,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Plus Therapeutics (PSTV) said Wednesday it priced an upsized underwritten public offering of about 39.5 million units at $0.38 each, expected to raise approximately $15 million in gross proceeds.Each ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","PSTV":"Plus Therapeutics, Inc.","LENZ":"Therapeutics","BK4007":"制药","BK4539":"次新股"},"translate_title":"Plus Therapeutics公开发行价格上调1500万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PSTV":1,"LENZ":1.5},"content_text":"Plus Therapeutics (PSTV) said Wednesday it priced an upsized underwritten public offering of about 39.5 million units at $0.38 each, expected to raise approximately $15 million in gross proceeds.Each unit comprised one share of common stock and one warrant, according to a statement.Underwriters have been granted a 30-day option to buy up to an additional 5.9 million shares and/or shares underlying the warrants to cover potential over-allotments, the company said.Net proceeds will be used for working capital and general corporate purposes, it added.The offering is expected to close on Thursday.Shares of the company were down more than 41% in recent trading.Price: 0.28, Change: -0.19, Percent Change: -41.44","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603641984","isCrawlerRequest":true}